HCP-1803
- Generic Name
- HCP-1803
A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension
Phase 3
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 249
- Registration Number
- NCT06438172
- Locations
- π°π·
Donggguk University Ilsan Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of
A Study to Evaluate the PK, Safety and Tolerability of HCP1803.
- First Posted Date
- 2023-02-10
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 20
- Registration Number
- NCT05723549
- Locations
- π°π·
Yangji Hospital, Seoul, Korea, Republic of
A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential Hypertension
Phase 3
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2022-05-05
- Last Posted Date
- 2023-09-26
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 361
- Registration Number
- NCT05362110
- Locations
- π°π·
Donggguk University Ilsan Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of
A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
Phase 2
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2021-07-13
- Last Posted Date
- 2022-07-14
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 245
- Registration Number
- NCT04959305
- Locations
- π°π·
Donggguk University Ilsan Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of
A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension
Phase 2
Completed
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2019-04-01
- Last Posted Date
- 2022-07-14
- Lead Sponsor
- Hanmi Pharmaceutical Company Limited
- Target Recruit Count
- 248
- Registration Number
- NCT03897868
- Locations
- π°π·
Donggguk University Ilsan Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath